Search clinical trials for: ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release

Total 5421 results

Brigham and Women's Hospital

Completed

Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data

Prostate Cancer

United States
University of Alabama at Birmingham

Completed

Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection

Renal Transplant Infection

United States
Austin V Stone

Terminated

Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury (SLAM)

Anterior Cruciate Ligament Tear | Tibial Meniscus Injuries | Tibial Meniscus Tears | Tibial Meniscus, Torn

United States
Memorial Sloan Kettering Cancer Center
Schering-Plough

Completed

Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma

Melanoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
Woman's
Pfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical...

Withdrawn

Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer (METBC)

Insulin Resistance | Breast Cancer Stage | Racial Bias

United States
University of California, San Francisco
The CARESTAR Foundation

Terminated

Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder

Substance Use | Alcohol Use Disorder | Alcohol Abuse or Dependence

United States
Mayo Clinic

Completed

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

Obesity

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); Medical Research Council

Completed

Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission

Leukemia

United States
Novo Nordisk A/S
Eli Lilly and Company; AstraZeneca; United BioSource, LLC

Enrolling by invitation

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Diabetes Mellitus, Type 2 | Diabetes | Weight Management | Medullary Thyroid Carcinoma

United States
Associazione Qol-one

Completed

Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients

Acute Myeloid Leukemia

Italy
Massachusetts General Hospital

Completed

A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

Alzheimer Dementia

United States
Trevi Therapeutics
Parexel

Completed

A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough (CANAL)

Cough | Idiopathic Pulmonary Fibrosis | Nalbuphine

United Kingdom
Baylor Research Institute

Completed

Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome

Type 2 Diabetes Mellitus | Chronic Kidney Disease | Left Ventricular Diastolic Dysfunction

United States
Temple University
Veloxis Pharmaceuticals

Completed

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Kidney Transplant

United States
MedVadis Research Corporation

Completed

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Chronic Pain

United States
Luye Pharma Group Ltd.
Parexel

Completed

A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD

Parkinson Disease

China
Titan Pharmaceuticals

Terminated

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Parkinson Disease

United States
Janssen Research & Development, LLC

Completed

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States
Supernus Pharmaceuticals, Inc.

Active, not recruiting

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)

Attention-Deficit/Hyperactivity Disorder

United States
Genovate Biotechnology Co., Ltd.,

Completed

BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Intermittent Claudication

United States
Genovate Biotechnology Co., Ltd.,

Terminated

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Intermittent Claudication

United States
The Cleveland Clinic

Active, not recruiting

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial (EMPOWER-T2D)

Obesity | Type 2 Diabetes

United States
Lorenzo Gallon

Completed

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

End Stage Renal Disease | Rejection of Renal Transplant

United States
Duke University

Terminated

Persistent Postpartum Hypertension Pilot Trial

Hypertension in Pregnancy

United States
Ultragenyx Pharmaceutical Inc

Terminated

Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Hereditary Inclusion Body Myopathy | GNE Myopathy | Distal Myopathy With Rimmed Vacuoles | Distal Myopathy, Nonaka Type | Quadriceps Sparing Myopathy

United States, Canada, United Kingdom, Israel, Italy, Bulgaria, France
Genuine Research Center, Egypt
Hikma Pharma

Completed

Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands)

Healthy

Egypt
NLS Pharmaceutics

Completed

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Narcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy

United States
Hillier, Sharon, PhD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Pharmacokinetics of Two Vaginal Film Formulations Containing the Integrase Inhibitor MK-2048 (FAME103)

Pharmacokinetics | Safety

United States
Rothman Institute Orthopaedics

Enrolling by invitation

Pain Relief After PrimaryTKA

Pain, Postoperative

United States
Rhodes Pharmaceuticals, L.P.

Completed

Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD

ADHD | Attention Deficit Hyperactivity Disorder

United States
Rhodes Pharmaceuticals, L.P.

Completed

A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD (EF003)

Attention Deficit Disorder With Hyperactivity

United States
Erasme University Hospital

Terminated

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Type 2 Diabetes | Pancreas | Incretinomimetics

Belgium
University of California, Los Angeles
Veloxis Pharmaceuticals

Active, not recruiting

Envarsus XR® in Adolescent Renal Transplant Recipients (EnvarsusXR)

Kidney Transplantation | Renal Transplantation | Grafting, Kidney

United States
Impax Laboratories, LLC

Completed

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Parkinson's Disease (Disorder)

United States, Czechia, France, Italy, Spain, Germany, Poland, United Kingdom
Lyndra Inc.
Worldwide Clinical Trials

Completed

A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules

Schizophrenia Schizoaffective

United States
AstraZeneca
Bristol-Myers Squibb

Completed

An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Type 2 Diabetes

Korea, Republic of, United States, Mexico, Puerto Rico, Philippines, Russian Federation, Ukraine
Baylor Research Institute

Active, not recruiting

Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen (Veloxis)

Compliance, Patient | Graft Failure | Heart Transplant Rejection

United States
Lyndra Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Opioid Use Disorder, Moderate
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
University of Pennsylvania

Completed

Biomarkers of Injectable Extended Release Naltrexone Treatment

Heroin Dependence | Opioid Dependence

United States
Janssen Korea, Ltd., Korea

Completed

A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Healthy

Korea, Republic of
Rhodes Pharmaceuticals, L.P.

Completed

Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting

ADHD | Attention Deficit Hyperactivity Disorder

United States
Lars Tanum
Oslo University Hospital; Haukeland University Hospital; The Hospital of Vestfold and other collaborators

Completed

Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery (NaltRec)

Opioid-use Disorder

Norway
TaiRx, Inc.

Completed

Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients

Advanced Cancer

Taiwan
Zogenix, Inc.

Completed

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

Renal Impairment
Zogenix, Inc.

Completed

To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

Healthy
Zogenix, Inc.

Completed

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

Postoperative Pain
Zogenix, Inc.

Completed

A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)

Healthy
Zogenix, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain

Osteoarthrosis

3

Subscribe